The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Half Year Trading Update

19 Jul 2018 07:00

RNS Number : 0832V
Science in Sport PLC
19 July 2018
 

19 JULY 2018

 

SCIENCE IN SPORT PLC

("SiS" or the "Company")

 

TRADING UPDATE

 

Science in Sport plc (AIM: SIS), a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts, is pleased to announce its trading update for the six months ended 30 June 2018.

 

Sales for the period grew 20% year on year ('YOY') to £9.94m (2017: £8.27m). Growth was underpinned by a strong performance in International markets, with 53% improvement YOY to £3.4m, including new markets as we continue to invest in the USA, Italy and Australia in line with our stated strategy. Despite the impact of the planned investment in a new e-commerce platform affecting two months, online channels grew 25% in the period and finished strongly, with 44% YOY growth for June and our scienceinsport.com business growing at 63% over the same period, with all key trading metrics well ahead of last year. Tough trading conditions in UK retail resulted in a 3% decline YOY, although we gained new customers and distribution towards the end of the period, which gives us confidence for the second half.

 

We closed the half with a record trading month across the business, generating sales of £2.22m (33% YOY) in June.

 

The Board remains confident in its outlook for the full year and beyond.

 

The Company will issue its Interim Results on Thursday 20 September.

 

 

For further information:

Science in Sport PLC

+44 (0) 20 7400 3700

Stephen Moon, CEO

 

Elizabeth Lake, Finance Director

 

 

Cenkos Securities - NOMAD and Broker

 

+44 (0) 20 7397 8925

Max Hartley

 

 

 

 

 

 

 

About Science in Sport plc

 

Science in Sport plc is a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts. SiS is a strong brand in the elite athlete community - in the 2016 Rio Olympics, 34 medal-winning athletes or teams used SiS products (compared with 24 in 2012).

The SiS core product ranges include: SiS GO, comprising energy powders, isotonic gels, energy bars and shots; SiS REGO, including protein-based recovery powders; SiS Protein, products specifically designed to contribute to athletes' lean muscle mass growth and maintenance; SiS Supplements, comprising BCAA Perform, Creatine, Beta Alanine and L Glutamine; SiS Athlete Health, vitamins and supplements range designed to support and maintain immune function, digestive health and bone health. SiS products are sold in a range of retail channels, including specialist sport retailers, major grocers, high street retailers and e-commerce websites.

SiS is currently the official sports nutrition partner to professional cycling organisations Team SKY, British Cycling, Cycling Australia and USA Cycling. SiS is also a partner to British Triathlon and Rock n Roll Marathon Series. Along with supplying over 60 professional English & Scottish League football teams, SiS is Sports Nutrition Partner to the world's most popular football club, Manchester United FC. In addition, Olympians Sir Chris Hoy MBE, Mark Cavendish MBE and Adam Peaty MBE are Brand Ambassadors.

SiS was founded in 1992 and is headquartered in Hatton Garden, London. Its manufacturing facility is in Nelson, Lancashire.

SiS shares are traded on the AIM market of the London Stock Exchange under the ticker symbol SIS.

For further information, please visit www.scienceinsport.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBLGDRUGBBGII

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.